// App-Quantinova.ai

1480 : Systemic immunotherapeutic efficacy of an immunocytokine, NHS-muIL12, in a superficial murine orthotopic bladder cancer model

Researchers

Presenter

  • Amanda J. Vandeveer

Principal Investigators

  • Jeffrey Schlom

  • John W. Greiner

Medical Centers

  • National Institute of Health, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • Cluster of differentiation 8A

  • Interleukin 12

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • Interferon Gamma

  • IL-12

  • Interleukin

  • Interferon

  • NHS-IL12

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved